- Patent Title: Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
-
Application No.: US15260855Application Date: 2016-09-09
-
Publication No.: US09884850B2Publication Date: 2018-02-06
- Inventor: Ralph Mazitschek , John H. van Duzer
- Applicant: Acetylon Pharmaceuticals, Inc.
- Applicant Address: US MA Boston
- Assignee: ACETYLON PHARMACEUTICALS, INC.
- Current Assignee: ACETYLON PHARMACEUTICALS, INC.
- Current Assignee Address: US MA Boston
- Agency: Lathrop Gage LLP
- Agent Brian C. Trinque
- Main IPC: C07D239/42
- IPC: C07D239/42 ; A61K31/505 ; C07D405/12
Abstract:
The present invention relates to pyrimidine hydroxy amide compounds, the use of such compounds in the inhibition of HDAC6, and the use of such compounds in the treatment of various diseases, disorders, or conditions related to HDAC6.
Public/Granted literature
- US20170096413A1 PYRIMIDINE HYDROXY AMIDE COMPOUNDS AS HDAC6 SELECTIVE INHIBITORS Public/Granted day:2017-04-06
Information query
